117 related articles for article (PubMed ID: 30932238)
1. Sweet syndrome in a patient with chronic myelogenous leukemia under dasatinib treatment.
Matsuda T; Ueda-Hayakawa I; Kambe N; Fujita S; Okamoto H
J Dermatol; 2019 Sep; 46(9):e317-e318. PubMed ID: 30932238
[No Abstract] [Full Text] [Related]
2. Neutrophilic Dermatosis Limited to Lipo-Lymphedematous Skin in a Morbidly Obese Woman on Dasatinib Therapy.
Ainechi S; Carlson JA
Am J Dermatopathol; 2016 Feb; 38(2):e22-6. PubMed ID: 26825166
[TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate- and dasatinib-induced eosinophilia in a patient with chronic myelocytic leukemia.
McGrath K; Stein B; Kalhagen L; Leighton L
Ann Allergy Asthma Immunol; 2017 Jul; 119(1):85-86. PubMed ID: 28499700
[No Abstract] [Full Text] [Related]
4. Hypopigmentation of the Skin and Hair Associated with Dasatinib Therapy.
Sharma V; Bagrodia V
Turk J Haematol; 2024 May; 41(2):116-117. PubMed ID: 37698254
[No Abstract] [Full Text] [Related]
5. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report.
Ochiai S; Sato Y; Minakawa A; Fukuda A; Fujimoto S
BMC Nephrol; 2019 Mar; 20(1):87. PubMed ID: 30845905
[TBL] [Abstract][Full Text] [Related]
7. Dasatinib-induced loss of eyebrows.
Naithani R
Br J Haematol; 2017 Nov; 179(3):362. PubMed ID: 28737227
[No Abstract] [Full Text] [Related]
8. Vascular events may predict the prognosis of patients with chronic myeloid leukemia.
Ureshino H; Kamachi K
Int J Hematol; 2020 Aug; 112(2):263. PubMed ID: 32533516
[No Abstract] [Full Text] [Related]
9. Chronic myelogenous leukemia presenting with osteonecrosis of the jaw as a rare but debilitating toxicity of dasatinib: a case report and literature review.
Won AM; Boddu P; Otun AO; Aponte-Wesson R; Chambers M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Oct; 126(4):e208-e211. PubMed ID: 29941400
[TBL] [Abstract][Full Text] [Related]
10. Is dasatinib-related pulmonary hypertension a clinical concern?
Szmit S
Future Oncol; 2015 Sep; 11(18):2491-4. PubMed ID: 26278893
[No Abstract] [Full Text] [Related]
11. Dasatinib-related left ventricular dysfunction in a patient with chronic myelogenous leukemia.
Kawanami Y; Yamaguchi K; Yamasaki S; Kagawa Y; Sato H; Watanabe N; Endo A; Yoshitomi H; Tanabe K
J Echocardiogr; 2024 Jun; 22(2):99-101. PubMed ID: 37314625
[No Abstract] [Full Text] [Related]
12. Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia.
Yim E; Choi YG; Nam YJ; Lee J; Kim JA
Korean J Intern Med; 2018 Mar; 33(2):446-448. PubMed ID: 26961484
[No Abstract] [Full Text] [Related]
13. Human herpesvirus 8-unrelated primary effusion lymphoma-like lymphoma following tyrosine kinase inhibitor treatment for chronic myelogenous leukemia.
Kojima M; Nakamura N; Amaki J; Numata H; Miyaoka M; Motoori T; Matsumoto K; Ando K
J Clin Exp Hematop; 2017; 57(2):69-73. PubMed ID: 29021516
[TBL] [Abstract][Full Text] [Related]
14. Interstitial pneumonitis associated with dasatinib: two case reports and literature review.
Ito Y; Tanigawa M; Iwamoto K; Nigi A; Itani H; Kondo S; Tokui T; Usui E; Tamaki S
Respir Investig; 2019 Sep; 57(5):506-509. PubMed ID: 31311724
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus colitis with presentation of hemorrhagic colitis in chronic myeloid leukemia during dasatinib therapy.
Chuang TM; Hsu CM; Liang PI; Hsiao HH
J Formos Med Assoc; 2021 Apr; 120(4):1155-1157. PubMed ID: 33127271
[No Abstract] [Full Text] [Related]
16. Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib.
Takekoshi D; Matsui Y; Akutsu T; Nishioka A; Kiritani A; Okuda K; Watanabe J; Miyagawa H; Utsumi H; Hashimoto M; Wakui H; Minagawa S; Hara H; Numata T; Noda Y; Makishima R; Ikegami M; Kawabata Y; Araya J; Kuwano K
Intern Med; 2020 Sep; 59(18):2297-2300. PubMed ID: 32536651
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Generic Dasatinib as a Second-line Treatment for Patients with Chronic Myeloid Leukemia: a Multicenter Retrospective Study in Hubei Province, China.
Chen LF; Yuan GL; Zhong ZD; Zou P; Li DJ; Bao Y; Ren HB; Meng L; Li WM
Curr Med Sci; 2018 Dec; 38(6):1005-1011. PubMed ID: 30536062
[TBL] [Abstract][Full Text] [Related]
18. Dasatinib-induced Pulmonary Hypertension.
Tamura Y; Tamura Y
Intern Med; 2022 Aug; 61(15):2245-2246. PubMed ID: 35110497
[No Abstract] [Full Text] [Related]
19. Infections in patients on BCR-ABL tyrosine kinase inhibitor therapy: cases and review of the literature.
Knoll BM; Seiter K
Infection; 2018 Jun; 46(3):409-418. PubMed ID: 29388066
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of domestic dasatinib in patients with newly diagnosed chronic myeloid leukemia in chronic phase].
Yu WJ; Du X; Wang WG; Lou J; Liu P; Meng L; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):318-321. PubMed ID: 32447937
[No Abstract] [Full Text] [Related]
[Next] [New Search]
